Pluri Secures Israel Funding for MAIT Cell Cancer Therapy, Teams Up With Bar-Ilan University to Target Solid Tumors

Benzinga10/28 19:03

プルリステム・セラピューティクス | 10-K：FY 2024 年度報告書

SEC09/19 04:02

Pluri Shares Rise After Manufacturing Accord With Kadimastem Set

MT Newswires07/18 23:24

Pluri Partners With Kadimastem to Advance Cell Therapy Products for Clinical Trials

Benzinga07/18 14:41

Pluri Announced €1M Proof Of Concept Agreement To Enhance Global Sustainable Vegetable Supply

Benzinga07/08 19:06

Pluri Appoints Liat Zalts as CFO

MT Newswires07/03 01:14